Could Building Gut Immunity Prevent Allergy Development Among Babies?

Contents

Next Steps

  1. Complete the study questionnaire
  2. Understand if you’re eligible to participate
Click Here

About the ADORED: Allergic Disease Onset Prevention Study


What if a baby is more prone to getting allergies because of poor gut immunity? The kind of bacteria in the human gut during infancy may affect the development of allergic disease later in life. Allergic diseases like atopic dermatitis (allergic eczema), food allergy, asthma and allergic rhinitis (hay fever) can significantly affect your child’s life. Currently, there are no approved treatments to prevent allergic diseases from happening.

An infant allergy development prevention research study is being done across multiple research sites in the United States and Australia. This study involves testing an investigational product to strengthen gut immunity and in turn, prevent allergic disease development. Researchers aim to understand if this investigational product could prevent the onset of allergic disease among newborns with a family history of having an allergic disease.

Improving the understanding between gut immunity and allergic diseases could pave the way for better approaches to reduce eczema, food allergy, asthma, and other allergic diseases. If there were a way to prevent your child from getting allergies, would you take it? Read on to learn more.


Why Participate?


  • You and your child will be contributing valuable information that may benefit other children in the future.
  • Your child may receive an investigational product that is the first of its kind at no cost.
  • The investigational product may help prevent the development of allergic disease which may enhance your child’s wellbeing.
  • Parents will be compensated for their time and reasonable travel expenses.
  • You and your child will be helping to advance baby allergy prevention research.

Your Rights


  • If you decide to participate in the study and later feel that you or your baby no longer wish to be part of it, you can withdraw at any time with no negative effect on your access to healthcare for your baby.
  • Any information that you provide will be kept strictly confidential, except as required by law.
  • Qualified health professionals will monitor your baby’s health as it relates to the study.

Who Can Participate?


  • Pregnant mothers who are at least 18 years old or mothers who have just given birth within the last 7 days:
    • For mothers who have just given birth, their baby’s birth weight must be:
      • For Australia: > 2.5kg to <4.5 kg
      • For USA: > 5.5lbs to < 9.9lbs
    • For mothers who have given birth, their baby must have been born at or after 35 weeks of gestation
  • The biological mother of the child, biological father of the child or biological sibling of the child (if applicable) must have a history of asthma, eczema, a food allergy or allergic rhinitis
  • The primary caregiver of the child and the child must be able to commit to this research study for over approximately 2 years

Key Study Details


The study team will explain the research study in its entirety but some details are:

  • There will be some sites that will offer for select study visits to be completed at home (Home Healthcare visits).
  • Siolta Therapeutics is sponsoring this research study. Siolta Therapeutics is testing an investigational product that may prevent atopic dermatitis (eczema), food allergy, asthma, and allergic rhinitis (hay fever). This potential treatment is an oral capsule containing powder that will be mixed with a small amount of breastmilk, formula, or milk product to be given to the child.
  • This product is investigational, which means that it is not yet approved for use outside of research studies like this one.

 

This research study is taking place in several locations. To see if there is a research site near you, please see below.

 


Research Site: Coastal Pediatric Research
Location: 2015 2nd Ave, Suite 102, Summerville, SC 29486
Lead Researcher: Stephen Stripling, MD, FAAP

 

Research Site: Seattle Allergy and Asthma Research
Location: 9725 3rd Ave NE #500, Seattle, WA 98115, United States
Lead Researcher: Dr. Daniel Petroni

 


Research Site: Arkansas Children’s Research Institute
Location: 13 Children’s Way, Slot 512-13 Little Rock, AR 72202, United States
Lead Researcher: Amy Scurlock, MD.

 

Research Site: University of Rochester School of Medicine and Dentistry
Location: 601 Elmwood Ave, Rochester, NY 14642, United States
Lead Researcher: Kirsi Järvinen-Seppo, MD, PhD

 


Research Site: Emory University
Location: 201 Dowman Dr, Atlanta, GA 30322, USA
Lead Researcher: Brian Vickery, MD

 

Research Site: University of Wisconsin-Madison
Location: 600 Highland Ave, Madison, WI
Lead Researcher: Daniel J. Jackson, MD

 

Research Site: Dell Children’s Medical Group
Location: 1301 Barbara Jordan Blvd, Suite 200 Austin, TX 78723
Lead Researcher: Pooja Varshney, MD


Study Locations


What’s Next?

  1. Click the link to enter your contact details and take the study questionnaire.
  2. If eligible, a member of the research team will contact you to discuss the study and answer any questions you may have.
Click Here to Check Your Eligibility for This Study

Is This Study Not For You?

Enter your details to be notified via email about new studies in your area

Send this to a friend